Welcome!

XML Authors: Jason Bloomberg, Jayaram Krishnaswamy, David Weinberger, Michael Nir, David Smith

News Feed Item

U.S. Census Bureau Daily Feature for April 22

WASHINGTON, April 22, 2014 /PRNewswire-USNewswire/ -- Following is the daily "Profile America" feature from the U.S. Census Bureau:

U.S. Census Bureau Logo.

LIFESAVING MEDICINE

Profile America Tuesday, April 22nd. One of world's most important medicines — insulin —became available for general use this month in 1923, saving the lives of millions of people suffering from diabetes. Insulin is a hormone produced by the pancreas and is critical in the processing of carbohydrates in the human body. It was first isolated the year before by a Canadian team led by Dr. Frederick Banting at the University of Toronto. The effect was like a miracle. One year, the disease was an automatic death sentence, the next, people who were affected had hopes of living full and productive lives. One of the first beneficiaries was the daughter of U.S. Secretary of State Charles Evans Hughes. Pharmaceutical manufacturing employs over 132,000 people in a $142 billion a year industry in the U.S. Profile America is in its 17th year as a public service of the U.S. Census Bureau.

Sources: http://www.historyorb.com/events/date/1923/april 
www.nobelprize.org 
http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ASM_2011_31GS201&prodType=table 
http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ECN_2007_US_00A1&prodType=table

Profile America is produced by the Center for New Media and Promotions of the U.S. Census Bureau. These daily features are available as produced segments, ready to air, on the Internet at http://www.census.gov (look for "Multimedia Gallery" by the "Newsroom" button). 

Logo - http://photos.prnewswire.com/prnh/20110428/DC91889LOGO

SOURCE U.S. Census Bureau

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.